Correlation Between Dr Reddys and ALZECURE PHARMA

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Dr Reddys and ALZECURE PHARMA at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Dr Reddys and ALZECURE PHARMA into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Dr Reddys Laboratories and ALZECURE PHARMA AB, you can compare the effects of market volatilities on Dr Reddys and ALZECURE PHARMA and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Dr Reddys with a short position of ALZECURE PHARMA. Check out your portfolio center. Please also check ongoing floating volatility patterns of Dr Reddys and ALZECURE PHARMA.

Diversification Opportunities for Dr Reddys and ALZECURE PHARMA

0.59
  Correlation Coefficient

Very weak diversification

The 3 months correlation between RDDA and ALZECURE is 0.59. Overlapping area represents the amount of risk that can be diversified away by holding Dr Reddys Laboratories and ALZECURE PHARMA AB in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on ALZECURE PHARMA AB and Dr Reddys is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Dr Reddys Laboratories are associated (or correlated) with ALZECURE PHARMA. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of ALZECURE PHARMA AB has no effect on the direction of Dr Reddys i.e., Dr Reddys and ALZECURE PHARMA go up and down completely randomly.

Pair Corralation between Dr Reddys and ALZECURE PHARMA

Assuming the 90 days trading horizon Dr Reddys is expected to generate 55.41 times less return on investment than ALZECURE PHARMA. But when comparing it to its historical volatility, Dr Reddys Laboratories is 7.09 times less risky than ALZECURE PHARMA. It trades about 0.02 of its potential returns per unit of risk. ALZECURE PHARMA AB is currently generating about 0.13 of returns per unit of risk over similar time horizon. If you would invest  18.00  in ALZECURE PHARMA AB on April 23, 2025 and sell it today you would earn a total of  12.00  from holding ALZECURE PHARMA AB or generate 66.67% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthWeak
Accuracy98.44%
ValuesDaily Returns

Dr Reddys Laboratories  vs.  ALZECURE PHARMA AB

 Performance 
       Timeline  
Dr Reddys Laboratories 

Risk-Adjusted Performance

Insignificant

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in Dr Reddys Laboratories are ranked lower than 1 (%) of all global equities and portfolios over the last 90 days. Despite nearly stable fundamental indicators, Dr Reddys is not utilizing all of its potentials. The current stock price disturbance, may contribute to mid-run losses for the stockholders.
ALZECURE PHARMA AB 

Risk-Adjusted Performance

OK

 
Weak
 
Strong
Compared to the overall equity markets, risk-adjusted returns on investments in ALZECURE PHARMA AB are ranked lower than 10 (%) of all global equities and portfolios over the last 90 days. Despite nearly fragile basic indicators, ALZECURE PHARMA reported solid returns over the last few months and may actually be approaching a breakup point.

Dr Reddys and ALZECURE PHARMA Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Dr Reddys and ALZECURE PHARMA

The main advantage of trading using opposite Dr Reddys and ALZECURE PHARMA positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Dr Reddys position performs unexpectedly, ALZECURE PHARMA can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in ALZECURE PHARMA will offset losses from the drop in ALZECURE PHARMA's long position.
The idea behind Dr Reddys Laboratories and ALZECURE PHARMA AB pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Portfolio Analyzer module to portfolio analysis module that provides access to portfolio diagnostics and optimization engine.

Other Complementary Tools

Insider Screener
Find insiders across different sectors to evaluate their impact on performance
Global Markets Map
Get a quick overview of global market snapshot using zoomable world map. Drill down to check world indexes
Fundamental Analysis
View fundamental data based on most recent published financial statements
Stocks Directory
Find actively traded stocks across global markets
AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities